Sentien CEO Brian Miller to Speak at Stem Cell Summit on April 7 in Boston

Sentien Biotechnologies CEO Brian Miller will be a Distinguished Speaker at the Stem Cell Summit to be held in Boston, MA from April 5-7, 2017.  Mr. Miller will address attendees during the Emerging Pipelines session of the Stem Cell Product Development & Commercialization segment of the Summit.  The title of Mr. Miller’s talk is “Developing a Novel Approach to Cell Therapy” during which he will discuss SBI-101, Sentien’s lead product, and its clinical applications.

“The Stem Cell Summit is particularly timely this year as we are in a very exciting time for Sentien,” said Mr. Miller.  “Next month, we will be moving our lead product into the clinic to treat patients with severe AKI, which represents a significant unmet medical need.”

The Summit will cover all areas of stem cell research from bench to bedside, including the biology, medicine, applications, regulations, product development, and the commercialization of stem cells.